Interferon-α Maintenance in Favorable-Risk AML | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Interferon-α Maintenance in Favorable-Risk AML | stella

Back to AML (Acute Myeloid Leukemia) trials

Recruiting

Plain-English translation of NCT07925554 on ClinicalTrials.gov ↗ · Source last updated November 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

China

Peking University People's Hospital, Beijing

Key details

Phase

Testing effectiveness

Sponsor

Peking University People's Hospital

Enrollment target

~30 participants

Started

March 2026

Primary completion

October 2027

Age range

18 Years – 70 Years

Last updated on clinicaltrials.gov in November 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Yuanjie Ding

Peking University People's Hospital

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.